Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 2
1982 1
1984 1
1988 1
1989 1
1990 2
1992 2
1997 2
2001 2
2002 2
2003 2
2004 5
2006 2
2007 1
2008 3
2009 3
2010 6
2011 4
2012 1
2013 5
2014 3
2015 4
2016 3
2017 6
2018 6
2019 10
2020 9
2021 14
2022 7
2023 10
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
Aghemo A, Alekseeva OP, Angelico F, Bakulin IG, Bakulina NV, Bordin D, Bueverov AO, Drapkina OM, Gillessen A, Kagarmanova EM, Korochanskaya NV, Kucheryavii UA, Lazebnik LB, Livzan MA, Maev IV, Martynov AI, Osipenko MF, Sas EI, Starodubova A, Uspensky YP, Vinnitskaya EV, Yakovenko EP, Yakovlev AA. Aghemo A, et al. Among authors: bakulin ig. Ann Med. 2022 Dec;54(1):1548-1560. doi: 10.1080/07853890.2022.2069854. Ann Med. 2022. PMID: 35635048 Free PMC article. Review.
Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, Nasyrova RF, Krupitsky EM, Shalikiani NV, Bakulin IG, Shcherbakov PL, Skorodumova LO, Larin AK, Kostryukova ES, Abdulkhakov RA, Abdulkhakov SR, Malanin SY, Ismagilova RK, Grigoryeva TV, Ilina EN, Govorun VM. Dubinkina VB, et al. Among authors: bakulin ig. Microbiome. 2017 Oct 17;5(1):141. doi: 10.1186/s40168-017-0359-2. Microbiome. 2017. PMID: 29041989 Free PMC article.
Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance.
Bujanda L, Nyssen OP, Ramos J, Bordin DS, Tepes B, Perez-Aisa A, Pavoni M, Castro-Fernandez M, Lerang F, Leja M, Rodrigo L, Rokkas T, Kupcinskas J, Jonaitis L, Shvets O, Gasbarrini A, Simsek H, Phull PS, Buzás GM, Machado JC, Boltin D, Boyanova L, Tonkić A, Marlicz W, Venerito M, Vologzanina L, Fadieienko GD, Fiorini G, Resina E, Muñoz R, Cano-Català A, Puig I, García-Morales N, Hernández L, Moreira L, Megraud F, Morain CO, Montes M, Gisbert JP; Hp-EuReg investigators; Hp-EuReg investigators. Bujanda L, et al. Am J Gastroenterol. 2024 Apr 1;119(4):646-654. doi: 10.14309/ajg.0000000000002600. Epub 2023 Nov 17. Am J Gastroenterol. 2024. PMID: 37983769
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial.
Wedemeyer H, Schöneweis K, Bogomolov P, Blank A, Voronkova N, Stepanova T, Sagalova O, Chulanov V, Osipenko M, Morozov V, Geyvandova N, Sleptsova S, Bakulin IG, Khaertynova I, Rusanova M, Pathil A, Merle U, Bremer B, Allweiss L, Lempp FA, Port K, Haag M, Schwab M, Zur Wiesch JS, Cornberg M, Haefeli WE, Dandri M, Alexandrov A, Urban S. Wedemeyer H, et al. Among authors: bakulin ig. Lancet Infect Dis. 2023 Jan;23(1):117-129. doi: 10.1016/S1473-3099(22)00318-8. Epub 2022 Sep 13. Lancet Infect Dis. 2023. PMID: 36113537 Clinical Trial.
Update on the Role of Rifaximin in Digestive Diseases.
Dumitrascu DL, Bakulin I, Berzigotti A, Cravo M, Gombošová L, Lukas M, Pietrzak A, Remes-Troche JM, Romero-Gómez M, Balmori MA, Gonçalves TC, Hamzaoui L, Juricek R, Moreira L, Neubauer K, Surdea-Blaga T, Tikhonov IN, Trna J, Ianiro G, Ponziani FR, Gasbarrini A. Dumitrascu DL, et al. Among authors: bakulin i. J Gastrointestin Liver Dis. 2023 Apr 1;32(1):92-109. doi: 10.15403/jgld-4871. J Gastrointestin Liver Dis. 2023. PMID: 37004222 Free article. Review.
[Diet therapy for irritable bowel syndrome].
Bakulin IG, Avalueva EB, Оrеshkо LS, Sitkin SI, Shevyakov MA, Serkova MU, Semenova EA. Bakulin IG, et al. Ter Arkh. 2020 Sep 3;92(8):118-127. doi: 10.26442/00403660.2020.08.000759. Ter Arkh. 2020. PMID: 33346471 Review. Russian.
[Liver cirrosis and complication risk management].
Bakulin IG, Oganezova IA, Skalinskaya MI, Skazyvaeva EV. Bakulin IG, et al. Ter Arkh. 2021 Aug 15;93(8):963-968. doi: 10.26442/00403660.2021.08.200917. Ter Arkh. 2021. PMID: 36286893 Russian.
112 results